Works by Tokito, Takaaki

Results: 46

Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis.

Published in:

Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 635, doi. 10.1513/AnnalsATS.202311-941OC

By:

Ikeda, Satoshi;
Ogura, Takashi;
Kato, Terufumi;
Kenmotsu, Hirotsugu;
Agemi, Yoko;
Tokito, Takaaki;
Ito, Kentaro;
Isomoto, Kohsuke;
Takiguchi, Yuichi;
Yoneshima, Yasuto;
Yokoyama, Toshihide;
Harada, Toshiyuki;
Tanzawa, Shigeru;
Kobayashi, Nobuaki;
Iwasawa, Tae;
Misumi, Toshihiro;
Okamoto, Hiroaki

Publication type:

Article

Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002).

Published in:

Japanese Journal of Clinical Oncology, 2025, v. 55, n. 1, p. 67, doi. 10.1093/jjco/hyae132

By:

Katakami, Nobuyuki;
Nagata, Kazuma;
Nakakura, Akiyoshi;
Okamoto, Tadashi;
Kaneda, Toshihiko;
Oki, Masahide;
Watanabe, Kana;
Tokito, Takaaki;
Amano, Yoshihiro;
Tamiya, Motohiro;
Morita, Satoshi;
Hatachi, Yukimasa

Publication type:

Article

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072

By:

Sakai, Hiroshi;
Morise, Masahiro;
Kato, Terufumi;
Matsumoto, Shingo;
Sakamoto, Tomohiro;
Kumagai, Toru;
Tokito, Takaaki;
Atagi, Shinji;
Kozuki, Toshiyuki;
Tanaka, Hiroshi;
Chikamori, Kenichi;
Shinagawa, Naofumi;
Takeoka, Hiroaki;
Bruns, Rolf;
Straub, Josef;
Schumacher, Karl Maria;
Paik, Paul K

Publication type:

Article

Implementation status and explanatory analysis of early advance care planning for Stage IV non-small cell lung cancer patients.

Published in:

Japanese Journal of Clinical Oncology, 2015, v. 45, n. 3, p. 261, doi. 10.1093/jjco/hyu207

By:

Tokito, Takaaki;
Murakami, Haruyasu;
Mori, Keita;
Osaka, Iwao;
Takahashi, Toshiaki

Publication type:

Article

Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.

Published in:

Cancers, 2024, v. 16, n. 7, p. 1409, doi. 10.3390/cancers16071409

By:

Mouri, Atsuto;
Watanabe, Satoshi;
Tokito, Takaaki;
Nagai, Yoshiaki;
Saida, Yu;
Imai, Hisao;
Yamaguchi, Ou;
Kobayashi, Kunihiko;
Kaira, Kyoichi;
Kagamu, Hiroshi

Publication type:

Article

Thoracic Angiosarcoma Arising from Chronic Tuberculous Pyothorax.

Published in:

Internal Medicine, 2025, v. 64, n. 7, p. 1085, doi. 10.2169/internalmedicine.4088-24

By:

Takayuki Horii;
Jun Sasaki;
Hidenobu Ishii;
Misa Sudou;
Reiko Takaki;
Takaaki Tokito;
Koichi Azuma;
Tomoaki Hoshino

Publication type:

Article

Proton Beam Therapy as a Curative Treatment for a Young Case of Unresectable Tracheal Adenoid Cystic Carcinoma.

Published in:

Internal Medicine, 2023, v. 62, n. 19, p. 2877, doi. 10.2169/internalmedicine.0574-22

By:

Takashi Kinoshita;
Hidenobu Ishii;
Yuki Sakazaki;
Koichi Azuma;
Jun Sasaki;
Takaaki Tokito;
Masaki Tominaga;
Etsuyo Ogou;
Tomotaka Kawayama;
Tomoaki Hoshino

Publication type:

Article

Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.

Published in:

British Journal of Cancer, 2024, v. 130, n. 11, p. 1783, doi. 10.1038/s41416-024-02662-2

By:

Haratani, Koji;
Nakamura, Atsushi;
Mamesaya, Nobuaki;
Sawa, Kenji;
Shiraishi, Yoshimasa;
Saito, Ryota;
Tanizaki, Junko;
Tamura, Yosuke;
Hata, Akito;
Tsuruno, Kosuke;
Sakamoto, Tomohiro;
Teraoka, Shunsuke;
Oki, Masahide;
Watanabe, Hiroshi;
Tokito, Takaaki;
Nagata, Kenji;
Masuda, Takeshi;
Nakamura, Yasushi;
Sakai, Kazuko;
Chiba, Yasutaka

Publication type:

Article

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1699, doi. 10.1007/s00520-014-2534-3

By:

Kimura, Madoka;
Naito, Tateaki;
Kenmotsu, Hirotsugu;
Taira, Tetsuhiko;
Wakuda, Kazushige;
Oyakawa, Takuya;
Hisamatsu, Yasushi;
Tokito, Takaaki;
Imai, Hisao;
Akamatsu, Hiroaki;
Ono, Akira;
Kaira, Kyoichi;
Murakami, Haruyasu;
Endo, Masahiro;
Mori, Keita;
Takahashi, Toshiaki;
Yamamoto, Nobuyuki

Publication type:

Article

Rechallenge treatment with a platinum-based regimen in patients with sensitive relapsed small-cell lung cancer.

Published in:

2018

By:

Naito, Yoshiko;
Yamada, Kazuhiko;
Imamura, Yohei;
Ishii, Hidenobu;
Matsuo, Norikazu;
Tokito, Takaaki;
Kinoshita, Takashi;
Azuma, Koichi;
Hoshino, Tomoaki

Publication type:

journal article

Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.

Published in:

International Journal of Clinical Oncology, 2014, v. 19, n. 1, p. 63, doi. 10.1007/s10147-012-0509-2

By:

Tokito, Takaaki;
Kenmotsu, Hirotsugu;
Watanabe, Reiko;
Ito, Ichiro;
Shukuya, Takehito;
Ono, Akira;
Nakamura, Yukiko;
Tsuya, Asuka;
Naito, Tateaki;
Murakami, Haruyasu;
Takahashi, Toshiaki;
Ohde, Yasuhisa;
Kondo, Haruhiko;
Endo, Masahiro;
Kameya, Toru;
Nakajima, Takashi;
Mori, Keita;
Yamamoto, Nobuyuki

Publication type:

Article

Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study.

Published in:

Thoracic Cancer, 2024, v. 15, n. 20, p. 1541, doi. 10.1111/1759-7714.15305

By:

Tsuboi, Masahiro;
Murakami, Haruyasu;
Harada, Hideyuki;
Sobue, Tomotaka;
Kato, Tomohiro;
Atagi, Shinji;
Tokito, Takaaki;
Mio, Tadashi;
Adachi, Hirofumi;
Kozuki, Toshiyuki;
Sone, Takashi;
Seike, Masahiro;
Toyooka, Shinichi;
Kitagawa, Hiroshi;
Koto, Ryo;
Yamazaki, Satoshi;
Horinouchi, Hidehito

Publication type:

Article

Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors.

Published in:

Thoracic Cancer, 2023, v. 14, n. 15, p. 1362, doi. 10.1111/1759-7714.14881

By:

Matsuo, Norikazu;
Azuma, Koichi;
Murotani, Kenta;
Murata, Daiki;
Matama, Goushi;
Kawahara, Akihiko;
Kojima, Takashi;
Tokito, Takaaki;
Hoshino, Tomoaki

Publication type:

Article

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor‐induced interstitial lung disease in patients with non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2023, v. 14, n. 1, p. 73, doi. 10.1111/1759-7714.14718

By:

Murata, Daiki;
Azuma, Koichi;
Matama, Goushi;
Zaizen, Yoshiaki;
Matsuo, Norikazu;
Murotani, Kenta;
Tokito, Takaaki;
Hoshino, Tomoaki

Publication type:

Article

Pazopanib for treating rhabdomyosarcoma in adult patients with poor performance status: A case report.

Published in:

Thoracic Cancer, 2022, v. 13, n. 21, p. 3080, doi. 10.1111/1759-7714.14669

By:

Nishii, Yuuya;
Sasaki, Jun;
Sudou, Misa;
Yano, Ryo;
Tokisawa, Saeko;
Takaki, Reiko;
Tokito, Takaaki;
Hoshino, Tomoaki

Publication type:

Article

A case of cytokine release syndrome accompanied with COVID‐19 infection during treatment with immune checkpoint inhibitors for non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 20, p. 2911, doi. 10.1111/1759-7714.14632

By:

Murata, Daiki;
Azuma, Koichi;
Tokisawa, Saeko;
Tokito, Takaaki;
Hoshino, Tomoaki

Publication type:

Article

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.

Published in:

Thoracic Cancer, 2020, v. 11, n. 4, p. 950, doi. 10.1111/1759-7714.13346

By:

Ishii, Hidenobu;
Azuma, Koichi;
Kawahara, Akihiko;
Kinoshita, Takashi;
Matsuo, Norikazu;
Naito, Yoshiko;
Tokito, Takaaki;
Yamada, Kazuhiko;
Akiba, Jun;
Hoshino, Tomoaki

Publication type:

Article

Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs.

Published in:

Thoracic Cancer, 2018, v. 9, n. 6, p. 754, doi. 10.1111/1759-7714.12646

By:

Masuda, Ken;
Tokito, Takaaki;
Azuma, Koichi;
Yanagida, Eriko;
Nakamura, Masayuki;
Naito, Yoshiko;
Matsuo, Norikazu;
Ishii, Hidenobu;
Yamada, Kazuhiko;
Akiba, Jun;
Hoshino, Tomoaki

Publication type:

Article

Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 661, doi. 10.1016/j.cllc.2024.07.001

By:

Yosuke Kakiuchi;
Koichi Saruwatari;
Kenta Murotani;
Takaaki Tokito;
Toyohisa Iriki;
Jun Iwakawa;
Yoshihiko Sakata;
Naoki Shingu;
Sho Saeki;
Megumi Inaba;
Akira Takaki;
Shunsuke Misono;
Takayuki Suetsugu;
Koichi Azuma;
Keiko Mizuno;
Takuro Sakagami

Publication type:

Article

Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.

Published in:

Cancer Science, 2024, v. 115, n. 4, p. 1296, doi. 10.1111/cas.16107

By:

Morise, Masahiro;
Kato, Terufumi;
Matsumoto, Shingo;
Inoue, Takako;
Sakamoto, Tomohiro;
Tokito, Takaaki;
Atagi, Shinji;
Kozuki, Toshiyuki;
Takeoka, Hiroaki;
Chikamori, Kenichi;
Shinagawa, Naofumi;
Tanaka, Hiroshi;
Horii, Eisuke;
Adrian, Svenja;
Bruns, Rolf;
Johne, Andreas;
Paik, Paul K.;
Sakai, Hiroshi

Publication type:

Article

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

Published in:

Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816

By:

Sugawara, Shunichi;
Tanaka, Kentaro;
Imamura, Fumio;
Yamamoto, Nobuyuki;
Nishio, Makoto;
Okishio, Kyoichi;
Hirashima, Tomonori;
Tanaka, Hiroshi;
Fukuhara, Tatsuro;
Nakahara, Yasuharu;
Kurata, Takayasu;
Katakami, Nobuyuki;
Okada, Morihito;
Horinouchi, Hidehito;
Udagawa, Hibiki;
Kasahara, Kazuo;
Satouchi, Miyako;
Saka, Hideo;
Tokito, Takaaki;
Hosomi, Yukio

Publication type:

Article

Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study.

Published in:

Cancer Science, 2021, v. 112, n. 8, p. 3255, doi. 10.1111/cas.14980

By:

Horinouchi, Hidehito;
Nogami, Naoyuki;
Saka, Hideo;
Nishio, Makoto;
Tokito, Takaaki;
Takahashi, Toshiaki;
Kasahara, Kazuo;
Hattori, Yoshihiro;
Ichihara, Eiki;
Adachi, Noriaki;
Noguchi, Kazuo;
Souza, Fabricio;
Kurata, Takayasu

Publication type:

Article

A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.

Published in:

2016

By:

Yamada, Kazuhiko;
Ichiki, Masao;
Takahashi, Kazuhisa;
Hisamatsu, Yasushi;
Takeoka, Hiroaki;
Azuma, Koichi;
Shukuya, Takehito;
Nishikawa, Kazuo;
Tokito, Takaaki;
Ishii, Hidenobu;
Hoshino, Tomoaki

Publication type:

journal article

Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1493, doi. 10.1007/s00280-013-2148-3

By:

Tokito, Takaaki;
Shukuya, Takehito;
Akamatsu, Hiroaki;
Taira, Tetsuhiko;
Ono, Akira;
Kenmotsu, Hirotsugu;
Naito, Tateaki;
Murakami, Haruyasu;
Takahashi, Toshiaki;
Endo, Masahiro;
Yamamoto, Nobuyuki

Publication type:

Article

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study.

Published in:

Cancer Medicine, 2020, v. 9, n. 18, p. 6597, doi. 10.1002/cam4.3306

By:

Horinouchi, Hidehito;
Atagi, Shinji;
Oizumi, Satoshi;
Ohashi, Kadoaki;
Kato, Tomohiro;
Kozuki, Toshiyuki;
Seike, Masahiro;
Sone, Takashi;
Sobue, Tomotaka;
Tokito, Takaaki;
Harada, Hideyuki;
Maeda, Tadashi;
Mio, Tadashi;
Shirosaka, Ikue;
Hattori, Kana;
Shin, Eisei;
Murakami, Haruyasu

Publication type:

Article

Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-57624-4

By:

Ishii, Hidenobu;
Azuma, Koichi;
Sakai, Kazuko;
Naito, Yoshiko;
Matsuo, Norikazu;
Tokito, Takaaki;
Yamada, Kazuhiko;
Hoshino, Tomoaki;
Nishio, Kazuto

Publication type:

Article

Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer.

Published in:

JAMA Network Open, 2023, v. 6, n. 12, p. e2347700, doi. 10.1001/jamanetworkopen.2023.47700

By:

Sakamoto, Tomohiro;
Matsubara, Taichi;
Takahama, Takayuki;
Yokoyama, Toshihide;
Nakamura, Atsushi;
Tokito, Takaaki;
Okamoto, Tatsuro;
Akamatsu, Hiroaki;
Oki, Masahide;
Sato, Yuki;
Tobino, Kazunori;
Ikeda, Satoshi;
Mori, Masahide;
Mimura, Chihiro;
Maeno, Ken;
Miura, Satoru;
Harada, Toshiyuki;
Nishimura, Kunihiro;
Hiraoka, Manabu;
Kenmotsu, Hirotsugu

Publication type:

Article

Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10467-w

By:

Miura, Satoru;
Koh, Yasuhiro;
Azuma, Koichi;
Yoshioka, Hiroshige;
Koyama, Kenichi;
Teraoka, Shunsuke;
Ishii, Hidenobu;
Kibata, Kayoko;
Ozawa, Yuichi;
Tokito, Takaaki;
Oyanagi, Jun;
Shimokawa, Toshio;
Kurata, Takayasu;
Yamamoto, Nobuyuki;
Tanaka, Hiroshi

Publication type:

Article

Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03781-8

By:

Murata, Daiki;
Azuma, Koichi;
Murotani, Kenta;
Kawahara, Akihiko;
Nishii, Yuuya;
Tokito, Takaaki;
Sasada, Tetsuro;
Hoshino, Tomoaki

Publication type:

Article

Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors.

Published in:

Cancer Medicine, 2023, v. 12, n. 19, p. 19471, doi. 10.1002/cam4.6549

By:

Murata, Daiki;
Azuma, Koichi;
Matsuo, Norikazu;
Murotani, Kenta;
Matama, Goushi;
Kawahara, Akihiko;
Sasada, Tetsuro;
Tokito, Takaaki;
Hoshino, Tomoaki

Publication type:

Article

Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients.

Published in:

Scientific Reports, 2016, p. 36458, doi. 10.1038/srep36458

By:

Matsuo, Norikazu;
Azuma, Koichi;
Sakai, Kazuko;
Hattori, Satoshi;
Kawahara, Akihiko;
Ishii, Hidenobu;
Tokito, Takaaki;
Kinoshita, Takashi;
Yamada, Kazuhiko;
Nishio, Kazuto;
Hoshino, Tomoaki

Publication type:

Article

Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti‐PD‐1 inhibitor.

Published in:

International Journal of Cancer, 2019, v. 144, n. 5, p. 1170, doi. 10.1002/ijc.31923

By:

Matsuo, Norikazu;
Azuma, Koichi;
Hattori, Satoshi;
Ohtake, Junya;
Kawahara, Akihiko;
Ishii, Hidenobu;
Tokito, Takaaki;
Yamada, Kazuhiko;
Shibata, Yuji;
Shimokawaji, Tadasuke;
Kondo, Tetsuro;
Kato, Terufumi;
Saito, Haruhiro;
Yamada, Kouzo;
Sasada, Tetsuro;
Hoshino, Tomoaki

Publication type:

Article

Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529).

Published in:

Radiation Oncology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13014-024-02577-5

By:

Tokito, Takaaki;
Yamada, Kazuhiko;
Ishii, Hidenobu;
Takiguchi, Yuichi;
Saito, Go;
Minato, Koichi;
Imai, Hisao;
Tanaka, Hiroshi;
Miura, Satoru;
Watanabe, Kageaki;
Koreeda, Yoshifusa;
Ono, Akira;
Furuya, Naoki;
Misumi, Toshihiro;
Hayakawa, Kazushige;
Ogo, Etsuyo;
Okamoto, Hiroaki

Publication type:

Article

The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.

Published in:

2018

By:

Yamauchi, Ryosuke;
Araki, Toshihiro;
Mitsuyama, Keiichi;
Tokito, Takaaki;
Ishii, Hidenobu;
Yoshioka, Shinichiro;
Kuwaki, Kotaro;
Mori, Atsushi;
Yoshimura, Tetsuhiro;
Tsuruta, Osamu;
Torimura, Takuji

Publication type:

journal article

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30676-y

By:

Fujimoto, Daichi;
Miura, Satoru;
Tomii, Keisuke;
Sumikawa, Hiromitsu;
Yoshimura, Kenichi;
Wakuda, Kazushige;
Oya, Yuko;
Yokoyama, Toshihide;
Kijima, Takashi;
Asao, Tetsuhiko;
Tamiya, Motohiro;
Nakamura, Atsushi;
Yoshioka, Hiroshige;
Tokito, Takaaki;
Murakami, Shuji;
Tamiya, Akihiro;
Yokouchi, Hiroshi;
Watanabe, Satoshi;
Yamaguchi, Ou;
Morinaga, Ryotaro

Publication type:

Article

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study.

Published in:

BMC Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11203-8

By:

Tokito, Takaaki;
Kolesnik, Oleksii;
Sørensen, Jens;
Artac, Mehmet;
Quintela, Martín Lázaro;
Lee, Jong-Seok;
Hussein, Maen;
Pless, Miklos;
Paz-Ares, Luis;
Leopold, Lance;
Daniel, Jeannie;
Munteanu, Mihaela;
Samkari, Ayman;
Xu, Lu;
Butts, Charles

Publication type:

Article

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.

Published in:

Investigational New Drugs, 2024, v. 42, n. 1, p. 136, doi. 10.1007/s10637-023-01411-1

By:

Nogami, Naoyuki;
Tokito, Takaaki;
Zenke, Yoshitaka;
Satouchi, Miyako;
Seto, Takashi;
Saka, Hideo;
Ohtani, Junko;
Han, Shirong;
Noguchi, Kazuo;
Nishio, Makoto

Publication type:

Article

Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy.

Published in:

Investigational New Drugs, 2021, v. 39, n. 4, p. 1150, doi. 10.1007/s10637-021-01069-7

By:

Matsuo, Norikazu;
Azuma, Koichi;
Kojima, Takashi;
Ishii, Hidenobu;
Tokito, Takaaki;
Yamada, Kazuhiko;
Hoshino, Tomoaki

Publication type:

Article

Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).

Published in:

Investigational New Drugs, 2021, v. 39, n. 2, p. 530, doi. 10.1007/s10637-020-01031-z

By:

Otani, Sakiko;
Sasaki, Jiichiro;
Nakahara, Yoshiro;
Fukui, Tomoya;
Igawa, Satoshi;
Naoki, Katsuhiko;
Bessho, Akihiro;
Hosokawa, Shinobu;
Fukamatsu, Nobuaki;
Nakamura, Yukiko;
Kasai, Takashi;
Sugiyama, Tomohide;
Tokito, Takaaki;
Seki, Nobuhiko;
Hamada, Akinobu;
Okamoto, Hiroaki;
Masuda, Noriyuki

Publication type:

Article

Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy.

Published in:

Investigational New Drugs, 2021, v. 39, n. 1, p. 269, doi. 10.1007/s10637-020-00983-6

By:

Ishii, Hidenobu;
Azuma, Koichi;
Kawahara, Akihiko;
Matsuo, Norikazu;
Tokito, Takaaki;
Hoshino, Tomoaki

Publication type:

Article

Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.

Published in:

Investigational New Drugs, 2020, v. 38, n. 6, p. 1854, doi. 10.1007/s10637-020-00943-0

By:

Nakashima, Kazuhisa;
Ozawa, Yuichi;
Daga, Haruko;
Imai, Hisao;
Tamiya, Motohiro;
Tokito, Takaaki;
Kawamura, Takahisa;
Akamatsu, Hiroaki;
Tsuboguchi, Yuko;
Takahashi, Toshiaki;
Yamamoto, Nobuyuki;
Mori, Keita;
Murakami, Haruyasu

Publication type:

Article

Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation.

Published in:

Investigational New Drugs, 2018, v. 36, n. 4, p. 715, doi. 10.1007/s10637-018-0586-9

By:

Tanaka, Midori;
Ishii, Hidenobu;
Moribuchi, Hayato;
Naito, Yoshiko;
Matsuo, Norikazu;
Nakamura, Masayuki;
Tokito, Takaaki;
Azuma, Koichi;
Yamada, Kazuhiko;
Hoshino, Tomoaki

Publication type:

Article

Aplastic anemia in a lung adenocarcinoma patient receiving pemetrexed.

Published in:

Investigational New Drugs, 2017, v. 35, n. 5, p. 662, doi. 10.1007/s10637-017-0462-z

By:

Matama, Goushi;
Tokito, Takaaki;
Takeoka, Hiroaki;
Hiraoka, Yuki;
Matsuo, Norikazu;
Nakamura, Masayuki;
Ishii, Hidenobu;
Kinoshita, Takashi;
Azuma, Koichi;
Yamada, Kazuhiko;
Hoshino, Tomoaki

Publication type:

Article

Ulcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumab.

Published in:

Investigational New Drugs, 2015, v. 33, n. 5, p. 1133, doi. 10.1007/s10637-015-0279-6

By:

Tanaka, Midori;
Ishii, Hidenobu;
Azuma, Koichi;
Saisho, Chika;
Matsuo, Norikazu;
Imamura, Yohei;
Tokito, Takaaki;
Kinoshita, Takashi;
Yamada, Kazuhiko;
Takedatsu, Hidetoshi;
Mitsuyama, Keiichi;
Hoshino, Tomoaki

Publication type:

Article

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).

Published in:

Targeted Oncology, 2024, v. 19, n. 3, p. 423, doi. 10.1007/s11523-024-01048-x

By:

Nishioka, Naoya;
Imai, Hisao;
Endo, Masahiro;
Notsu, Akifumi;
Doshita, Kosei;
Igawa, Satoshi;
Yokouchi, Hiroshi;
Ninomiya, Takashi;
Tokito, Takaaki;
Soda, Sayo;
Fujiwara, Takasato;
Asao, Tetsuhiko;
Nakamichi, Shinji;
Kawamura, Takahisa;
Inomata, Minehiko;
Nakashima, Kazuhisa;
Ito, Kentaro;
Goto, Yasuhiro;
Umeda, Yukihiro;
Hirai, Soichi

Publication type:

Article

Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature.

Published in:

Endocrine Journal, 2024, v. 71, n. 11, p. 1069, doi. 10.1507/endocrj.EJ24-0126

By:

Hiroshi Katoh;
Tomoya Mitsuma;
Riku Okamoto;
Kanako Naito;
Takaaki Tokito;
Mariko Kikuchi;
Takafumi Sangai

Publication type:

Article